KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teva Pharmaceutical Industries (TEVA) EPS (Weighted Average and Diluted): 2009-2024

Historic EPS (Weighted Average and Diluted) for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -$1.45.

  • Teva Pharmaceutical Industries' EPS (Weighted Average and Diluted) rose 194.87% to $0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.60, marking a year-over-year increase of 170.59%. This contributed to the annual value of -$1.45 for FY2024, which is 190.00% down from last year.
  • As of FY2024, Teva Pharmaceutical Industries' EPS (Weighted Average and Diluted) stood at -$1.45, which was down 190.00% from -$0.50 recorded in FY2023.
  • Over the past 5 years, Teva Pharmaceutical Industries' EPS (Weighted Average and Diluted) peaked at $0.38 during FY2021, and registered a low of -$3.64 during FY2020.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$1.45 (2024), whereas its average is -$1.38.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' EPS (Weighted Average and Diluted) skyrocketed by 110.44% in 2021, and later slumped by 678.95% in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' EPS (Weighted Average and Diluted) (Yearly) stood at -$3.64 in 2020, then surged by 110.44% to $0.38 in 2021, then tumbled by 678.95% to -$2.20 in 2022, then spiked by 77.27% to -$0.50 in 2023, then slumped by 190.00% to -$1.45 in 2024.